drugset / Trial / NCT01037101
D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
Unknown
80 enrolled
CAMC Health System
University of Charleston · collabWest Virginia University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study will determine the effects of D-Cycloserine (DCS) on fear reduction in patients diagnosed with phobia of heights (acrophobia) undergoing one session of three hours of virtual reality exposure therapy (VRET) or in vivo exposure therapy (IVET).
Timeline
- Start
- 2009-07
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cycloserine | Small molecule | 50 mg | — |
Indications
No indication recorded.